Please enable JavaScript to view advertisements.
×
App Icon
The Standard e-Paper
Kenya’s Boldest Voice
★★★★ - on Play Store
Download App

Ebola drug treating Kenyan Covid-19 patients ‘within two days’

A nurse injects a lady with the AstraZeneca vaccine at Kenya Medical Research Institute (KEMRI) Nairobi. [Elvis Ogina,Standard]

Dr Daniel Yumbya was not responding quickly to treatment after contracting Covid-19 in February.

The CEO of the Kenya Medical Practitioners and Dentists Council (KMPDC) had suffered persistent headache, high temperatures, nausea and lost his taste feeling. However, the coronavirus symptoms did not surprise him since he’s a frontline worker. He was only shaken when shortness of breath forced him to use supplemental oxygen in the five days he was admitted at the Nairobi West Hospital.

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902